Effect of Empagliflozin Beyond Glycemic Control: Cardiovascular Benefit in Patients with Type 2 Diabetes and Established Cardiovascular Disease
AuthID
P-00R-J4X
P-00R-J4X
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service